Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Top 10 High-Yield Dividend Stocks To Consider In May 2025
10:23pm, Thursday, 01'st May 2025
Q2 2025 began with market volatility due to tariff announcements, resulting in SPY losing 0.87% and VYM declining by 3.54%. Since inception, my watchlist has a CAGR of 14.61%, outperforming SPY and VY
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
10:05am, Thursday, 01'st May 2025
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
5 Dogs of the Dow To Buy This May
09:58am, Thursday, 01'st May 2025
While the strategy involves buying the Dogs of the Dow at the start of January, there are a few still worth betting on as markets regain lost ground.
Should Investors Buy Merck Stock After These Huge Risks?
11:30am, Wednesday, 30'th Apr 2025
The performance of healthcare companies is relatively uncorrelated with broader macroeconomic growth.
Stock Market Crash: 3 High-Yielding Dividend Stocks Near Their 52-Week Lows to Buy Right Now
10:00am, Wednesday, 30'th Apr 2025
One great thing about a crash or downturn in the markets is that it can allow you to go bargain hunting fairly easily. Many stocks have been falling this year, and if you're a dividend investor, you k
3 Names I Picked Up In The Latest Market Slump
05:17am, Wednesday, 30'th Apr 2025
When the market is reaching toward all-time highs, I tend to start building a cash pile. When the market starts to get quite volatile and brings declines, that can create opportunities for putting som
Merck to invest $1B in new US plant to make blockbuster cancer treatment Keytruda
02:24pm, Tuesday, 29'th Apr 2025
The new facility will produce biologic drugs and Keytruda, becoming Merck's first in-house US site to make the blockbuster cancer treatment, the company said.
Merck Breaks Ground on New $1 Billion Biologics Center of Excellence in Wilmington, Delaware
06:45am, Tuesday, 29'th Apr 2025
RAHWAY, N.J.--(BUSINESS WIRE)--Merck Breaks Ground on New $1 billion Biologics Center of Excellence in Wilmington, Delaware.
Merck to invest $1 billion in new Delaware plant to boost US manufacturing, WSJ reports
06:01am, Tuesday, 29'th Apr 2025
U.S. drugmaker Merck is investing $1 billion in a new Delaware plant to expand its domestic production as it prepares to deal with the looming impact from President Donald Trump's tariffs, the Wall St
Merck will build a $1 billion plant to expand U.S. manufacturing as tariff threats loom
05:30am, Tuesday, 29'th Apr 2025
The Delaware facility will ensure a domestic supply of biologic drugs including the cancer drug Keytruda.
Should You Buy, Sell or Hold MRK Stock After Q1 Earnings Beat?
08:50am, Monday, 28'th Apr 2025
We believe investors with a long-term horizon should stay invested in MRK stock, while short-term investors may exit the stock.
2 Must-Own Dividends At Bargain Basement Prices
08:31am, Monday, 28'th Apr 2025
April's market volatility has created dividend bargains, allowing investors to pick high-quality blue-chip stocks with strong balance sheets and long-term return potential. Merck, trading at a low P/E
Germany's Merck Set to Buy SpringWorks in $3.9 Billion Deal
02:33am, Monday, 28'th Apr 2025
The deal to acquire the U.S. biopharmaceutical company confirms an earlier report in The Wall Street Journal.
Merck KGaA, Darmstadt, Germany to Acquire SpringWorks Therapeutics to Accelerate Sustainable Growth of Healthcare Business
02:13am, Monday, 28'th Apr 2025
– Purchase price of $47 per share in cash represents an equity value of approximately $3.9 billion, or an enterprise value of $3.4 billion (€3.0 billion) – – Planned acquisition will immediate
DARMSTADT, Germany--(BUSINESS WIRE)--Merck KGaA, Darmstadt, Germany (DAX: MRK), a leading science and technology company, and SpringWorks Therapeutics, Inc. (Nasdaq: SWTX), a Stamford, Connecticut-bas
